GL1X · GenesisL1 explorer

Research workbench

Non-receptor protein tyrosine phosphatase SHP2 in complex with allosteric inhibitor TNO155

Analyse Non-receptor protein tyrosine phosphatase SHP2 in complex with allosteric… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7JVM
Type
protein
Length
965 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 11
EC
3.1.3.48
UniProt
Q06124
Ligands
VKS, PO4
Pockets
12 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein48630% helix, 26% strandQ06124
BTyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein47932% helix, 27% strandQ06124

Ligands and binding sites

  • VKS · (3S,4S)-8-{6-amino-5-[(2-amino-3-chloropyridin-4-yl) sulfanyl]pyrazin-2-yl}-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17900.680.7559empty
23660.670.8037VKS, PO4
34120.650.7937VKS, PO4
41360.540.8224empty
51120.490.8125empty

Interfaces

1 interface between chains.

  • A–B · 164 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 7JVM · Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor TNO155 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.